Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of CancerJohan Maertens, Catherine Cordonnier, Tom Lodewyck et al.|Clinical Infectious Diseases|2022Cited by 62
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile NeutropeniaMonica Fung, Sophia Koo, Jane Kim et al.|PLoS ONE|2015Cited by 59